Results 241 to 250 of about 357,915 (267)

Virus safety in bio products

Journal of Chemical Technology & Biotechnology, 1994
openaire   +1 more source

Virus safety of plasma derivatives

Transfusion Science, 1990
openaire   +1 more source

Efficacy and safety of a third-generation oncolytic herpes virus G47Δ in models of human esophageal carcinoma

Molecular Therapy - Oncolytics, 2021
Sugawara Kotaro, Yasuyuki Seto, Tomoki Tōdō   +2 more
exaly  

The oncologic burden of hepatitis C virus infection: A clinical perspective

Ca-A Cancer Journal for Clinicians, 2017
Nassim Hammoudi, Terri Lynn Shigle, Ahmed S Kaseb   +2 more
exaly  

Safety of Virus-Resistant Transgenic Plants Two Decades After Their Introduction: Lessons from Realistic Field Risk Assessment Studies

Annual Review of Phytopathology, 2007
Marc Fuchs, Dennis Gonsalves
exaly  

Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial

Lancet, The, 2015
Zonghui Hu, Mario Roederer, Barney Graham   +2 more
exaly  

Safety and Attenuation of Vaccinia Virus

R. Mark L. Buller, Gregory J. Palumbo
openaire   +1 more source

Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity

Vaccine, 2004
Qigai He, Bin Wu, Zili Li
exaly  

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)

Open Forum Infectious Diseases, 2015
Rebecca Sheets, Georgia Tomaras, Mary Allen   +2 more
exaly  

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Lancet, The, 2018
Rebecca S Pelc, Zonghui Hu, Colleen Kelley   +2 more
exaly